https://www.ninlaro.com/sites/default/files/2022-12/ninlaro_patient-_conversation_starter.pdf 2025-01-31T18:38:14+00:00 0.5 https://www.ninlaro.com/sites/default/files/2022-12/ninlaro_patient_dosing_calendar-.pdf 2025-01-31T18:37:13+00:00 0.5 https://www.ninlaro.com/sites/default/files/2022-12/ninlaro_patient_experience_brochure_spanish.pdf 2025-01-31T18:34:35+00:00 0.5 https://www.ninlaro.com/sites/default/files/2022-12/understanding_multiple_myeloma_lab_tests.pdf 2025-01-31T18:35:10+00:00 0.5 https://www.ninlaro.com/sites/default/files/2023-03/patient-information.pdf 2025-01-31T18:39:29+00:00 0.5 https://www.ninlaro.com/sites/default/files/resources/ninlaro-patient-relapse-brochure.pdf 2025-01-31T18:36:02+00:00 0.5 https://www.ninlaro.com/sites/default/files/resources/ninlaro-prescribing-information.pdf 2025-01-31T18:41:29+00:00 0.5 https://www.ninlaro.com/sites/default/files/resources/multiple-myeloma-lab-tests-and-tracker-spanish-version.pdf 2025-01-31T18:39:40+00:00 0.5 https://www.ninlaro.com/sites/default/files/resources/package-instructions.pdf 2025-01-31T18:38:54+00:00 0.5 https://www.ninlaro.com/sites/default/files/resources/patient-experience-guide.pdf 2025-01-31T18:39:16+00:00 0.5